Raymond James Financial (RJF) EVP reports 2,128-share RSU vesting in Form 4

Rhea-AI Filing Summary

Raymond James Financial (RJF) executive reports vesting of stock awards. On 12/02/2025, an executive officer (EVP, General Counsel, Secretary) acquired 2,128 shares of Raymond James Financial common stock at a price of $0.0000 per share through the vesting of Performance Restricted Stock Units granted on 12/15/2022. After this transaction, the reporting person beneficially owned 27,563 shares of common stock directly and 540 shares indirectly through an Employee Stock Ownership Plan account, which includes shares accumulated through November 24, 2025. The RSUs vested based on the company attaining specified average after-tax return-on-equity levels, modified by relative total shareholder return versus a peer group over a three-year measurement period.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Santelli Jonathan N

(Last) (First) (Middle)

880 CARILLON PARKWAY

(Street)

ST. PETERSBURG FL 33716

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYMOND JAMES FINANCIAL INC [ RJF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Gen Counsel, Secy

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2025		A		2,128(1)	A	$0.0000	27,563	D
Common Stock								540(2)	I	ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Vesting of Performance Restricted Stock Units (PRSUs) granted on 12/15/2022.

2. Includes shares of common stock acquired under the reporting person's Employee Stock Ownership Plan (ESOP) account through November 24, 2025.

Remarks:

This Form 4 reports the acquisition by the reporting person of common stock resulting from the vesting of Restricted Stock Units (RSUs) granted on 12/15/2022 based on the company's attaining certain levels of average after-tax return-on-equity, as modified by the company's relative total shareholder return compared to a peer group, over a three-year measurement period.

	/s/ Jonathan N. Santelli by Jonathan J. Doyle as Attorney-in-Fact	12/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Raymond James Financial (RJF) report in this Form 4?

The filing reports that an executive officer of Raymond James Financial acquired 2,128 shares of common stock on 12/02/2025 at a price of $0.0000 per share through vesting of performance-based restricted stock units.

How many Raymond James Financial (RJF) shares does the reporting person own after this transaction?

Following the reported transaction, the executive beneficially owned 27,563 shares of Raymond James Financial common stock directly and 540 shares indirectly through an Employee Stock Ownership Plan (ESOP) account.

What triggered the vesting of the Raymond James Financial (RJF) performance RSUs?

The Performance Restricted Stock Units vested based on the company attaining certain levels of average after-tax return-on-equity, adjusted by the company’s relative total shareholder return compared to a peer group over a three-year measurement period.

What is the role of the reporting person at Raymond James Financial (RJF)?

The reporting person is an officer of Raymond James Financial, serving as Executive Vice President, General Counsel, and Secretary.

Were any derivative securities reported in this Raymond James Financial (RJF) Form 4?

The table for derivative securities is included, but this filing details only the acquisition of non-derivative common stock resulting from the vesting of restricted stock units.

Does this Raymond James Financial (RJF) Form 4 involve an open-market stock purchase or sale?

No open-market trade is reported. The 2,128 shares were acquired at $0.0000 per share as a result of the vesting of Performance Restricted Stock Units previously granted on 12/15/2022.